Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Jurnal Darma Agung
Bintoro Adi Saputro
Sekolah Tinggi Pariwisata, Mataram
Humanities Civil Engineering, Building, Construction & Architecture Computer Science & IT Decision Sciences, Operations Research & Management Languange, Linguistic, Communication & Media Law, Crime, Criminology & Criminal Justice Library & Information Science Materials Science & Nanotechnology Social Sciences

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
INTRAVENOUS IMMUNOGLOBULIN THERAPY FOR KAWASAKI DISEASE (CASE REPORT) Bintoro Adi Saputro; Ramzi Syamlan
JURNAL DARMA AGUNG Vol 31 No 3 (2023): JUNI
Publisher : Lembaga Penelitian dan Pengabdian kepada Masyarakat Universitas Darma Agung (LPPM_UDA)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.46930/ojsuda.v31i3.3262

Abstract

Kawasaki disease (KD) is acute vasculitis with an unidentified cause. The prevalence of Kawasaki disease is greater in developed countries or regions, also known as developed areas. Throughout 2021, two cases of complete Kawasaki were identified at Perkebunan Jember Klinik Hospital. Using a Harada score of 3, intravenous immunoglobulin (IGIV) treatment screening was calculated. In general, IGIV is used to reduce the risk of abnormalities/damage to the coronary arteries. The purpose of this study is to identify the diagnostic criteria and indications for administering IGIV to children with Kawasaki disease. Qualitative Method with the case report approach. Patients diagnosed with Kawasaki disease must receive therapy and care based on their symptoms and conditions. Kawasaki disease can be treated with a number of different drugs. IGIV can be delivered to Kawasaki disease patients as a form of treatment. IGIV treatment based on Harada Score. Kawasaki disease is a condition that is rarely recognized by the general public. The resulting conclusions are as follows Complete Kawasaki disease is diagnosed by five days of persistent fever plus 4 of the 5 classic symptoms. Screening with a scoring system is needed in making decisions about giving IGIV.
Co-Authors Ramzi Syamlan